Encapsulation of vinorelbine in polymeric nanoparticles improves efficacy in cancer cells and reduces inflammation in non-cancer cells

Alexander Cryer (London, United Kingdom), Alexander Cryer, Pakatip Ruenraroengsak, Teresa Tetley, Andrew Thorley

Source: International Congress 2016 – Late-breaking translational research in lung cancer
Session: Late-breaking translational research in lung cancer
Session type: Oral Presentation
Number: 1527
Disease area: Thoracic oncology

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Alexander Cryer (London, United Kingdom), Alexander Cryer, Pakatip Ruenraroengsak, Teresa Tetley, Andrew Thorley. Encapsulation of vinorelbine in polymeric nanoparticles improves efficacy in cancer cells and reduces inflammation in non-cancer cells. Eur Respir J 2016; 48: Suppl. 60, 1527

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of 17-oxo-DHA alone and in combination with gemcitabine on lung cancer cell growth
Source: International Congress 2016 – Late-breaking translational research in lung cancer
Year: 2016


Antitumor efficacy of the double suicide genesin lung cancer cells
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015

Comparative analysis of cisplatin treatment in in vitro 3D lung microtissue and monolayer cell cultures
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015

Aromatase inhibition alters the mechanical properties of non small-cell lung cancer cells affecting cell movement
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013


Anti-cancer effects of bevacizumab and cisplatin on cancer cell invaded human ex-vivo lung tissue
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016

Placenta-derived conditioned medium with anti-tumor properties on human NSCLC
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015

Abnormal abundance of senescent fibroblasts in the tumor stroma of non-small cell lung cancer patients
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013

Dihydroartemisinin combined with cisplatinum induced apoptosis and related mechanism research in human lung adenocarcinoma H1299 cells
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016

The influence of erythropoietin on growth and survival in non-small cell lung cancer cell lines
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015


MMP-9 responsive mesoporous silica nanoparticles for local drug delivery to NSCLC cells
Source: International Congress 2014 – Thoracic tumours: news from the lab
Year: 2014

Exploring the volatome of different cancer cell lines
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015

Molecular mechanisms of inhibition of lung cancer stem cells invasion by a novel soy isoflavone VF166
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016


In vitro and in vivo application of the GILUPI cell collector system for the isolation and characterization of circulating tumor cells (CTCs) in lung cancer patients
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015

RBM5 overexpression reverses acquired resistance to gefitinib in PC9/AB2 NSCLC cells
Source: International Congress 2016 – Late-breaking translational research in lung cancer
Year: 2016

Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015

Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015


Cell intrinsic and environmental factors influencing human bronchial epithelial cell migration
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016

Metabolic modification as a potential therapeutics approach in lung cancer
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013


The effect of surgical specimen-derived phosphorus and lead concentrations in non-small cell lung cancer patients on disease course
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016

Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014